Connect With Us!
Procelys - Yeast Extract, Fermentation & Biothechologies - Lesaffre
17381
page-template,page-template-full_width,page-template-full_width-php,page,page-id-17381,page-fermentation-masters,ajax_fade,page_not_loaded,,qode-title-hidden,side_menu_slide_from_right,qode-child-theme-ver-1.0.0,qode-theme-ver-9.5,wpb-js-composer js-comp-ver-4.12,vc_responsive

Event’s presentation

Join us on Thursday, October 29  for the first edition of our virtual event,

You’ll hear from industry experts on probiotic market trends in the Asia-Pacific region, Procelys’ long-
standing expertise in fermentation, quality yeast-based nutrients for supporting probiotic strains, and a
case study from a prominent probiotic producer.

5 talks of 25-minute each will be streamed live on LiveStorm Thursday, October 29.

the context

In 2020, the global probiotics market is a USD $1 billion market. The Asia-Pacific region has the largest share
in the market at over 30,5% and is rapidly growing in response to global competition. One of the largest
drivers behind probiotic use is probiotics’ ability to boost immune function. Preliminary reports connecting
probiotics to better outcomes after COVID-19 infection have boosted global probiotics sales in 2020.

To be successful in a crowded landscape, probiotics producers must effectively please consumers while also implementing cost-effective production strategies that optimize both quality and productivity of their strains. One of the most important factors for producing consistent, stable, high-quality probiotics is a high-quality, clean nitrogen source.

Developing a relationship with an established, long-standing,
and trusted partner that can deliver the quality solution can
ensure probiotics strains production’s success.

THE PROGRAM

During this half-day, virtual live event, hear from industry leaders from Euromonitor, Novozymes, CHR Hansen India,

Lesaffre and Procelys. You’ll come away with a better understanding of the current market

and expected trends and how you can optimize your probiotics strains for success in a booming market.

Starting at 2:00 PM UTC+8.

Preventative health: spotlight on immunity and probiotics

Ms Maria Mascaraque

Euromonitor, Industry Manager for Food and Nutrition

The emergence of the global pandemic has boosted consumer interest in being healthy. As a result, demand for targeted functionality as a key component of wellbeing has been expedited.

> Read more

> Reduce

The emergence of the global pandemic has boosted consumer interest in being healthy. As a result, demand for targeted functionality as a key component of wellbeing has been expedited.

Among all, immunity has been one of the biggest concerns during the COVID-19 health crisis and has the potential to spur innovation moving forward. This will benefit ingredients that have been traditionally associated with immune support, including probiotics.

This presentation will give an overview of the increased interest in immunity boosting products and the performance of probiotic-related categories like yoghurt. It will also delve into new opportunities for manufacturers moving forward.

About Maria :

Based in London, Maria has more than 8 years of experience in the industry. She drives the content and quality of Euromonitor’s global food industry research, provide global expertise and forward-thinking insights. She identifies the latest product developments and key market trends.

María advises clients on food and nutrition trends and has a special interest in the dairy industry, plant-based eating and health and wellness trends. She holds a PhD in Nutrition from Complutense University, Spain.

Furqa_Ali

Starting at 2:00 PM UTC+8.

High-quality manufacturing processes & science backed Probiotics to enhance Health & Nutrition naturally

Dr. Furqan Ali

Christian Hansen India, Senior Research Scientist- Fermentation & Microbiology

Emerging scientific evidences suggest that the supplementation of probiotics has positive effects on the gut microbiota and overall health. Moreover probiotics are one of the fastest growing ingredients, and ever more people are becoming aware of good bacteria.

> Read more

> Reduce

Emerging scientific evidences suggest that the supplementation of probiotics has positive effects on the gut microbiota and overall health. Moreover probiotics are one of the fastest growing ingredients, and ever more people are becoming aware of good bacteria.

At Chr. Hansen, we have over 145 years of expertise in developing and producing bacteria that may support human health. In order to confer health benefits, probiotics must be safe, clinically documented, live when consumed and manufactured with highest quality.

The probiotic strains we develop at Chr. Hansen are supported by strong science, are clinically documented, shelf stable, and are manufactured to the highest quality. We will be discussing and sharing our experiences in developing probiotics.

About Furqan Ali :

Furqan Ali is a Senior Scientist at Chr. Hansen, India, focusing on the new production process technologies for probiotics and dairy cultures via fermentation and encapsulation approach.

He holds Ph.D., degree in biotechnology from Indian Institute of Integrative Medicine (CSIR, Jammu, India) with specialization in Microbiology, Biochemistry and Industrial Biotechnology (Fermentation). He has 9+ years of industrial experience (post- PhD.,) in probiotics, prebiotics, and functional food product applications studies (preclinical and clinical).

His research expertise includes the development and commercialization of new probiotic strains, natural prebiotic fibres, herbal products, lead molecules, conduct pre-clinical (in-vitro and animal studies) and human clinical studies to support and validate the commercial product clinical claims such as management of diabetes, cardiovascular health, weight management, skin health, digestive disorders (IBS, functional abdominal pain and functional dyspepsia) and dyslipidemia.

Gilles Portrait

Starting at 2:00 PM UTC+8.

Insights from a leader in the fermentation technology entering the probiotics industry

Mr. Gilles Jequier

Novozymes One Health, Head of Sales at Novozymes One Health

Novozymes, the world leader in biological solutions, has established Novozymes One Health to enter the human health market under a new platform.

> Read more

> Reduce

Novozymes, the world leader in biological solutions, has established Novozymes One Health to enter the human health market under a new platform.

The company’s mission is to help people live healthier and better lives by rethinking tomorrow within human health and finding the one-in-a-trillion verifiable solutions of probiotics and enzymes. From oral to gut health, Novozymes drive product developments based on strong scientific hypotheses and identified consumer demand.

Through this presentation, you will learn how profound health challenges related to modern lifestyles can be solved in new ways by an innovative approach.

About Gilles:

Based in Basel, Gilles is in charge of the global B2B human health sales of Novozymes with his team. Since getting his master in food science from the ETH in Zurich, he has been managing innovation projects in the food and health industry in different R&D, marketing and sales positions.

Ramona

Starting at 2:00 PM UTC+8.

Effect of NuCel® yeast based nutrients on probiotic modes of action in vitro

Dr. Ramona Cernat

Lesaffre, R&D Manager, corporate R&D – the In Vitro Platform

Probiotics are becoming increasingly important in basic and clinical research, but they are also a subject of considerable economic interest due to their expanding popularity. They are live microorganisms which, when administered in adequate amounts, confer a health benefit to the host. There are different mechanisms of action through which probiotics can impact human health such as inhibition of pathogenic bacteria, immunomodulatory effects, stimulation of gut barrier function and metabolic function.

> Read more

> Reduce

Probiotics are becoming increasingly important in basic and clinical research, but they are also a subject of considerable economic interest due to their expanding popularity. They are live microorganisms which, when administered in adequate amounts, confer a health benefit to the host. There are different mechanisms of action through which probiotics can impact human health such as inhibition of pathogenic bacteria, immunomodulatory effects, stimulation of gut barrier function and metabolic function.

Although in vitro studies or animal models cannot prove a probiotic effect, they can be used to characterise a possible mechanism of probiotic action, determine the safety of probiotic microorganisms or convey other knowledge of probiotic strains.

NuCel® is a specifically designed range of yeast based nutrients (YBN) that Procelys provides for the probiotics industry. Besides investigations into YBN influence on probiotic strain industrial production, Procelys has also started pioneering investigations into YBN effect on probiotic modes of actions such as the immunomodulatory effects and the stimulation of gut barrier function.

This work is being conducted in collaboration with the In Vitro Platform – Lesaffre corporate R&D, at the preliminary data presented here indicates the ability of the selected NuCel® nutrients to modulate the intestinal epithelial integrity and the expression of anti-inflammatory IL10 in Lactobacillus rhamnosus GG (LGG) and Lactobacillus plantarum BC3019 strains. The differences in key performance parameters (biomass and metabolite) of L. plantarum BC3019 strain in the presence of the selected NuCel® nutrients are also presented.

About Ramona :

Former Associate Professor, PhD in Microbiology at the University of Bucharest – Romania, Ramona received in 2008 a Marie Curie Intraeuropean postdocoral fellowship (7th Framework Programme, European Commission) for studying the effect of antibiotic administration on the composition of the human intestinal microbiota, the prevalence of antibiotic resistance bacteria and the development of antibiotic- associated diarrhoea.

This fellowship, hosted by the Rowett Research Institute – Aberdeen, UK was followed in 2012 by a postdoctoral fellowship on sub-acute ruminal acidosis at the same institute, which included an insightful first year experience in biotech environment at Chr Hansen – Denmark. The biotech experience continued in December 2014 when Ramona joined AHI department at Chr Hansen, first as scientist and, from May 2015 as senior scientist. In December 2017 Ramona took up her current position as manager and creator of the In Vitro Platform in corporate R&D at Lesaffre International, France.

Saiful_Hazulul

Starting at 2:00 PM UTC+8.

NuCel®- Yeast Based Nutrients to face challenges in Probiotics Industrial Manufacturing.

Mr. Saiful Fazulul Haq

Procelys, Technical Support Manager Asia Pacific

Yeast Based Nutrients*, including extracts and peptones, are common ingredients in industrial media formulations for probiotic strains.

> Read more

> Reduce

Yeast Based Nutrients*, including extracts and peptones, are common ingredients in industrial media formulations for probiotic strains.

Procelys is one of the largest yeast based products manufacturers and provides high performing, GMO-free, animal-free, allergen free nutrients for probiotic strains production. NuCel® is a specifically designed range of yeast based nutrients for the probiotics industry and it provides a natural source of proteins, peptides, free amino acids, nucleotides, vitamins, microelements and various growth factors.

In response to the rising demand for high quality and consistent ingredients, Procelys Applications Labs have developed bioperformance assays to investigate YBN* influence on probiotic strains industrial production. The correct selection and combination of yeast based nutrients is critical to having the optimal media formulation which ensures high biomass levels and maintains viability and vitality throughout the production process. In this presentation, you will discover how Procelys can accentuate your Probiotics Industrial Manufacturing with our products and services.

About Saiful

Saiful is responsible for developing and providing technical expertise to the customers closely working with application labs, business managers, other internal stakeholders (production, marketing etc.)

He develops technical and scientific cooperation with various international institutes/universities and contribute to Procelys Innovation Strategies.

Saiful represents Procelys at various scientific conferences, symposiums and tradeshows with technical briefs presenting yeast based product performances. His expertise in Probiotics have contributed to generating new strains, improved production processes and published articles. Previously he worked as Senior Scientist in Pharma & Food Sector expertise in biologics production, strain improvement, bio performance  in bacterial, yeast and mammalian expression systems